OPRX vs TECH · rev $92.1M vs P/E 65, rev $1.22B
OPTIMIZERx Corp (OPRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
OPTIMIZERx Corp (OPRX) is a health information services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported OPRX revenue for 2024-12-31 was $92.1M. Net income was -$20.1M. Revenue was up 28.8% from 2023-12-31 to 2024-12-31. OPRX currently screens at market cap $234.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
OPRX currently screens at market cap $234.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the OPRX and TECH stock pages for the full models.
Not investment advice.